| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances and prospects of RNA delivery nanoplatforms for cancer therapy
|
Attia, Mohamed S.
|
|
|
15 |
1 |
p. 52-96
|
artikel
|
| 2 |
Akkermansia muciniphila-derived acetate activates the hepatic AMPK/SIRT1/PGC-1α axis to alleviate ferroptosis in metabolic-associated fatty liver disease
|
Zhuge, Aoxiang
|
|
|
15 |
1 |
p. 151-167
|
artikel
|
| 3 |
Caffeic acid-vanadium nanozymes treat skin flap ischemia-reperfusion injury through macrophage reprogramming and the upregulation of X-linked inhibitors of apoptotic proteins
|
Zhao, Xinyu
|
|
|
15 |
1 |
p. 592-610
|
artikel
|
| 4 |
Cerebral endothelial 3-mercaptopyruvate sulfurtransferase improves ischemia-induced cognitive impairment via interacting with protein phosphatase 2A
|
Zhu, Li
|
|
|
15 |
1 |
p. 314-330
|
artikel
|
| 5 |
Cocrystal pleomorphism-inspired drug nanoassembly for pulmonary-endothelium targeting and pulmonary hypertension treatment
|
Zoulikha, Makhloufi
|
|
|
15 |
1 |
p. 557-570
|
artikel
|
| 6 |
Cover Story
|
|
|
|
15 |
1 |
p. xviii
|
artikel
|
| 7 |
Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition via autophagy-dependent ferroptosis
|
Lu, Yuan
|
|
|
15 |
1 |
p. 424-437
|
artikel
|
| 8 |
Design, synthesis and pharmacological evaluation of 1,2,3,4-tetrahydrobenzofuro[2,3-c]pyridine derivatives as p21-activated kinase 4 inhibitors for treatment of pancreatic cancer
|
Li, Yang
|
|
|
15 |
1 |
p. 438-466
|
artikel
|
| 9 |
Dimeric natural product panepocyclinol A inhibits STAT3 via di-covalent modification
|
Li, Li
|
|
|
15 |
1 |
p. 409-423
|
artikel
|
| 10 |
DiPTAC: A degradation platform via directly targeting proteasome
|
Tu, Yutong
|
|
|
15 |
1 |
p. 661-664
|
artikel
|
| 11 |
Discovery of a novel AhR–CYP1A1 axis activator for mitigating inflammatory diseases using an in situ functional imaging assay
|
Zhang, Feng
|
|
|
15 |
1 |
p. 508-525
|
artikel
|
| 12 |
Discovery of a novel thiophene carboxamide analogue as a highly potent and selective sphingomyelin synthase 2 inhibitor for dry eye disease therapy
|
Yang, Jintong
|
|
|
15 |
1 |
p. 392-408
|
artikel
|
| 13 |
Drofenine as a Kv2.1 inhibitor alleviated AD-like pathology in mice through Aβ/Kv2.1/microglial NLRP3/neuronal Tau axis
|
Lu, Jian
|
|
|
15 |
1 |
p. 371-391
|
artikel
|
| 14 |
Drug discovery targeting thyroid hormone receptor β (THRβ) for the treatment of liver diseases and other medical indications
|
Wang, Kean
|
|
|
15 |
1 |
p. 35-51
|
artikel
|
| 15 |
Dual activation of GCGR/GLP1R signaling ameliorates intestinal fibrosis via metabolic regulation of histone H3K9 lactylation in epithelial cells
|
Liu, Han
|
|
|
15 |
1 |
p. 278-295
|
artikel
|
| 16 |
Emerging therapeutic strategies: The potential of caffeic acid-vanadium nanozymes in modulating macrophage function and reducing skin flap ischemia–reperfusion injury
|
Fu, Jintao
|
|
|
15 |
1 |
p. 665-666
|
artikel
|
| 17 |
Facilitation of mucosal healing by estrogen receptor β in ulcerative colitis through suppression of branched-chain amino acid transport and subsequent triggering of autophagy in colonic epithelial cells
|
Guo, Yilei
|
|
|
15 |
1 |
p. 168-187
|
artikel
|
| 18 |
Free fatty acid receptor-4 regulates T-cell-mediated allogeneic reaction through activating an aryl hydrocarbon receptor pathway
|
Duah, Maxwell
|
|
|
15 |
1 |
p. 224-238
|
artikel
|
| 19 |
GSFM: A genome-scale functional module transformation to represent drug efficacy for in silico drug discovery
|
Tian, Saisai
|
|
|
15 |
1 |
p. 133-150
|
artikel
|
| 20 |
Gut microbiota-derived tryptophan metabolites regulated by Wuji Wan to attenuate colitis through AhR signaling activation
|
Jing, Wanghui
|
|
|
15 |
1 |
p. 205-223
|
artikel
|
| 21 |
In situ tumor cell engineering reverses immune escape to enhance immunotherapy effect
|
Liu, Shujun
|
|
|
15 |
1 |
p. 627-641
|
artikel
|
| 22 |
Iron and siRNA co-encapsulated ferritin nanocages induce ferroptosis synergistically for cancer therapy
|
Liu, Danni
|
|
|
15 |
1 |
p. 526-541
|
artikel
|
| 23 |
Microglial APOE4 promotes neuron degeneration in Alzheimer's disease through inhibition of lipid droplet autophagy
|
Mao, Meng
|
|
|
15 |
1 |
p. 657-660
|
artikel
|
| 24 |
Nanoengineered cargo with targeted in vivo Foxo3 gene editing modulated mitophagy of chondrocytes to alleviate osteoarthritis
|
Chen, Manyu
|
|
|
15 |
1 |
p. 571-591
|
artikel
|
| 25 |
Natural product mediated mesenchymal–epithelial remodeling by covalently binding ENO1 to degrade m6A modified β-catenin mRNA
|
Chen, Tianyang
|
|
|
15 |
1 |
p. 467-483
|
artikel
|
| 26 |
N 6-Methyladenosine modification of circDcbld2 in Kupffer cells promotes hepatic fibrosis via targeting miR-144-3p/Et-1 axis
|
Zhu, Sai
|
|
|
15 |
1 |
p. 296-313
|
artikel
|
| 27 |
Optimized lipid nanoparticles enable effective CRISPR/Cas9-mediated gene editing in dendritic cells for enhanced immunotherapy
|
Mao, Kuirong
|
|
|
15 |
1 |
p. 642-656
|
artikel
|
| 28 |
Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications
|
Dash, Umesh Chandra
|
|
|
15 |
1 |
p. 15-34
|
artikel
|
| 29 |
Real-time platelet P2Y12 receptor occupancy as a promising pharmacodynamics biomarker for bridging the gap between PK/PD of clopidogrel therapy
|
Li, Haipeng
|
|
|
15 |
1 |
p. 484-493
|
artikel
|
| 30 |
Real-world efficacy and safety of azvudine in hospitalized older patients with COVID-19 during the omicron wave in China: A retrospective cohort study
|
Zhu, Yuanchao
|
|
|
15 |
1 |
p. 123-132
|
artikel
|
| 31 |
Recent advances in the bench-to-bedside translation of cancer nanomedicines
|
Liu, Yang
|
|
|
15 |
1 |
p. 97-122
|
artikel
|
| 32 |
Regulation of histidine metabolism by Lactobacillus Reuteri mediates the pathogenesis and treatment of ischemic stroke
|
Hu, Kangrui
|
|
|
15 |
1 |
p. 239-255
|
artikel
|
| 33 |
“Relative symmetry with electronegativity of different key-groups” strategy for MRGPRX2 antagonist design and its effect on antigen-induced pulmonary inflammation
|
Lu, Jiayu
|
|
|
15 |
1 |
p. 494-507
|
artikel
|
| 34 |
Reversing metabolic reprogramming by CPT1 inhibition with etomoxir promotes cardiomyocyte proliferation and heart regeneration via DUSP1 ADP-ribosylation-mediated p38 MAPK phosphorylation
|
Tang, Luxun
|
|
|
15 |
1 |
p. 256-277
|
artikel
|
| 35 |
Synergistic metabolic modulation of fibroblast-like synoviocytes via targeted dual prodrug nanoparticles to mitigate rheumatoid arthritis
|
Li, Shaobing
|
|
|
15 |
1 |
p. 542-556
|
artikel
|
| 36 |
Table of Contents
|
|
|
|
15 |
1 |
p. iii-xvii
|
artikel
|
| 37 |
The applications and advances of artificial intelligence in drug regulation: A global perspective
|
Fu, Lixia
|
|
|
15 |
1 |
p. 1-14
|
artikel
|
| 38 |
The homotherapy for heteropathy: GCGR/GLP1R pathway in fibrotic diseases
|
Sun, Yang
|
|
|
15 |
1 |
p. 667-668
|
artikel
|
| 39 |
The PGAM5–NEK7 interaction is a therapeutic target for NLRP3 inflammasome activation in colitis
|
Gao, Cheng-Long
|
|
|
15 |
1 |
p. 349-370
|
artikel
|
| 40 |
Tumor-intrinsic PRMT5 upregulates FGL1 via methylating TCF12 to inhibit CD8+ T-cell-mediated antitumor immunity in liver cancer
|
Sun, Jiao
|
|
|
15 |
1 |
p. 188-204
|
artikel
|
| 41 |
Unlocking the role of wound microbiome in diabetic, burn, and germ-free wound repair treated by natural and synthetic scaffolds
|
Xu, Zeyu
|
|
|
15 |
1 |
p. 611-626
|
artikel
|
| 42 |
YOD1 regulates microglial homeostasis by deubiquitinating MYH9 to promote the pathogenesis of Alzheimer's disease
|
Sun, Jinfeng
|
|
|
15 |
1 |
p. 331-348
|
artikel
|
Tijdschrift beschrijving